
Bristol Myers' Experimental Breast Cancer Treatment Demonstrates Survival Gains in Advanced Patients
Bristol Myers Squibb's experimental breast cancer drug showed survival improvements in advanced patients, though stock declined slightly following the announcement.
BMYCELGrbreast cancerPhase 3 trial